These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 10628809)

  • 1. Neoglycolipid conjugates of foscarnet with enhanced antiviral activity in cells infected with human cytomegalovirus and herpes simplex virus type 1.
    Maloisel JL; Pring BG; Tidén AK; Dypbukt J; Ljungdahl-Ståhle E
    Antivir Chem Chemother; 1999 Nov; 10(6):333-45. PubMed ID: 10628809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alkylthioglycerol prodrugs of foscarnet: synthesis, oral bioavailability and structure-activity studies in human cytomegalovirus-, herpes simplex virus type 1- and human immunodeficiency virus type 1-infected cells.
    Beadle JR; Kini GD; Aldern KA; Gardner MF; Wright KN; Richman DD; Hostetler KY
    Antivir Chem Chemother; 1998 Jan; 9(1):33-40. PubMed ID: 9875375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alkoxy propane prodrugs of foscarnet: effect of alkyl chain length on in vitro antiviral activity in cells infected with HIV-1, HSV-1 and HCMV.
    Kini GD; Beadle JR; Xie H; Aldern KA; Richman DD; Hostetler KY
    Antiviral Res; 1997 Sep; 36(1):43-53. PubMed ID: 9330760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrasting effects of W781V and W780V mutations in helix N of herpes simplex virus 1 and human cytomegalovirus DNA polymerases on antiviral drug susceptibility.
    Piret J; Goyette N; Eckenroth BE; Drouot E; Götte M; Boivin G
    J Virol; 2015 Apr; 89(8):4636-44. PubMed ID: 25673718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid prodrugs of phosphonoacids: greatly enhanced antiviral activity of 1-O-octadecyl-sn-glycero-3-phosphonoformate in HIV-1, HSV-1 and HCMV-infected cells, in vitro.
    Hostetler KY; Kini GD; Beadle JR; Aldern KA; Gardner MF; Border R; Kumar R; Barshak L; Sridhar CN; Wheeler CJ; Richman DD
    Antiviral Res; 1996 Jun; 31(1-2):59-67. PubMed ID: 8793009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and in vitro activities of a new antiviral duplex drug linking Zidovudine (AZT) and Foscarnet (PFA) via an octadecylglycerol residue.
    Schott H; Hamprecht K; Schott S; Schott TC; Schwendener RA
    Bioorg Med Chem; 2009 Jan; 17(1):303-10. PubMed ID: 19010684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and antiviral activity of 1-O-octadecyl-2-O-alkyl-sn-glycero-3-foscarnet conjugates in human cytomegalovirus-infected cells.
    Kini GD; Hostetler SE; Beadle JR; Aldern KA
    Antiviral Res; 1997 Nov; 36(2):115-24. PubMed ID: 9443668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benzimidazole ribonucleosides: design, synthesis, and antiviral activity of certain 2-(alkylthio)- and 2-(benzylthio)-5,6-dichloro-1-(beta-D-ribofuranosyl)benzimidazoles.
    Devivar RV; Kawashima E; Revankar GR; Breitenbach JM; Kreske ED; Drach JC; Townsend LB
    J Med Chem; 1994 Sep; 37(18):2942-9. PubMed ID: 8071942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of non-nucleoside analogs of toyocamycin, sangivamycin, and ++thiosangivamycin: influence of various 7-substituents on antiviral activity.
    Renau TE; Wotring LL; Drach JC; Townsend LB
    J Med Chem; 1996 Feb; 39(4):873-80. PubMed ID: 8632411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and antiviral evaluation of 2-chloro-5,6-dihalo-1-beta-D-ribofuranosylbenzimidazoles as potential agents for human cytomegalovirus infections.
    Zou R; Drach JC; Townsend LB
    J Med Chem; 1997 Feb; 40(5):811-8. PubMed ID: 9057868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotypic characterization of the DNA polymerase and sensitivity to antiviral compounds of foscarnet-resistant herpes simplex virus type 1 (HSV-1) derived from a foscarnet-sensitive HSV-1 strain.
    Saijo M; Suzutani T; Morikawa S; Kurane I
    Antimicrob Agents Chemother; 2005 Feb; 49(2):606-11. PubMed ID: 15673740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic in vitro interactions between (22S,23S)-3beta-bromo-5alpha,22,23-trihydroxystigmastan-6-one and acyclovir or foscarnet against herpes simplex virus type 1.
    Talarico LB; Castilla V; Ramirez JA; Galagovsky LR; Wachsman MB
    Chemotherapy; 2006; 52(1):38-42. PubMed ID: 16340198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and antiviral evaluation of 2-substituted 4,5-dichloro- and 4,6-dichloro-1-beta-D-ribofuranosylbenzimidazoles as potential agents for human cytomegalovirus infections.
    Zou R; Drach JC; Townsend LB
    J Med Chem; 1997 Feb; 40(5):802-10. PubMed ID: 9057867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and antiviral activity of certain 2,5,6-trihalo-1-(beta-D-ribofuranosyl)benzimidazoles.
    Townsend LB; Devivar RV; Turk SR; Nassiri MR; Drach JC
    J Med Chem; 1995 Sep; 38(20):4098-105. PubMed ID: 7562945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Method Based on Real-Time Cell Analysis for Drug Susceptibility Testing of Herpes Simplex Virus and Human Cytomegalovirus.
    Piret J; Goyette N; Boivin G
    J Clin Microbiol; 2016 Aug; 54(8):2120-7. PubMed ID: 27252463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal toxicology and duration of efficacy of a novel antiviral lipid prodrug of ganciclovir in liposome formulation.
    Cheng L; Hostetler KY; Chaidhawangul S; Gardner MF; Beadle JR; Keefe KS; Bergeron-Lynn G; Severson GM; Soules KA; Mueller AJ; Freeman WR
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1523-32. PubMed ID: 10798672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro anti-human cytomegalovirus activity of liposome-encapsulated foscarnet.
    Gümbel HO; Rückert DG; Cinatl J; Rabenau H; Doerr HW; Ohrloff C
    Ger J Ophthalmol; 1994 Jan; 3(1):5-8. PubMed ID: 8142882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow transplantation in a child with Wiskott-Aldrich syndrome latently infected with acyclovir-resistant (ACV(r)) herpes simplex virus type 1: emergence of foscarnet-resistant virus originating from the ACV(r) virus.
    Saijo M; Yasuda Y; Yabe H; Kato S; Suzutani T; De Clercq E; Niikura M; Maeda A; Kurane I; Morikawa S
    J Med Virol; 2002 Sep; 68(1):99-104. PubMed ID: 12210436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and antiproliferative and antiviral activity of carbohydrate-modified pyrrolo[2,3-d]pyridazin-7-one nucleosides.
    Meade EA; Wotring LL; Drach JC; Townsend LB
    J Med Chem; 1997 Feb; 40(5):794-801. PubMed ID: 9057866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo activity of 1-O-hexadecylpropanediol-3-phospho-ganciclovir and 1-O-hexadecylpropanediol-3-phospho-penciclovir in cytomegalovirus and herpes simplex virus infections.
    Hostetler KY; Rybak RJ; Beadle JR; Gardner MF; Aldern KA; Wright KN; Kern ER
    Antivir Chem Chemother; 2001 Jan; 12(1):61-70. PubMed ID: 11437323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.